Premphase and Ranexa drug interactions - a phase IV clinical study of FDA data
Summary:
We study 14,020 people who take Premphase (estrogens, conjugated; medroxyprogesterone acetate) and Ranexa (ranolazine). There is no drug interaction reported.
The study analyzes what interactions people have when they take Premphase and Ranexa. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Premphase?
Premphase has active ingredients of estrogens, conjugated; medroxyprogesterone acetate. eHealthMe is studying from 2,262 Premphase users. Check the latest studies of Premphase.
What is Ranexa?
Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.
No report is found.
Do you take Premphase and Ranexa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on estrogens, conjugated; medroxyprogesterone acetate and ranolazine (the active ingredients of Premphase and Ranexa, respectively), and Premphase and Ranexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Brivaracetam cause Weakness? - 5 seconds ago
- Drug interactions of Periactin and Ultram - 10 seconds ago
- Drug interactions of Venlafaxine Hydrochloride and Glucophage - 17 seconds ago
- Drug interactions of Febuxostat and Janumet - 32 seconds ago
- Drug interactions of Marinol and Calquence - 59 seconds ago
- Could Meloxicam cause Gastric Bypass? - a minute ago
- Could Phenytoin cause Weight Increased? - a minute ago
- How effective is Atenolol for Essential Hypertension? - a minute ago
- Could Calquence cause Abdominal Pain? - a minute ago
- Drug interactions of Selenium and Baclofen - a minute ago